However, more recent studies demonstrated that endogenous insulin is significantly and positively correlated with skeletal muscles mass; low insulin levels are associated with sarcopenia, and insulin therapy improved the skeletal muscle index and muscle mass and delayed the progression of sarcopenia [127,128,129,130]. The gene discussed is INS; the disease is sarcopenia.